MARYNA YACINTHE: Open Payments
NPI 1558703090 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 38 payments from 14 companies in 2025. Trend: 2023 $564 · 2024 $641 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $140 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Amgen Inc. | 2 | $36 |
| PFIZER INC. | 2 | $36 |
| Medtronic, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: CAMZYOS, LEQVIO, ELIQUIS, VERQUVO, JARDIANCE, FARXIGA, Kerendia, REPATHA.
Industry payments across NC — which companies pay providers there.
